Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk

Oncogene volume 24, pages 4138–4148 (2005)Cite this article

Abstract

Patients with Barrett's esophagus (BE) are at increased risk of developing esophageal adenocarcinoma (EAC). Clinical neoplastic progression risk factors, such as age and the length of the esophageal BE segment, have been identified. However, improved molecular biomarkers predicting increased progression risk are needed for improved risk assessment and stratification. Using real-time quantitative methylation-specific PCR, we screened 10 genes (HPP1, RUNX3, RIZ1, CRBP1, 3-OST-2, APC, TIMP3, p16, MGMT, p14) for promoter hypermethylation in 77 EAC, 93 BE, and 64 normal esophagus (NE) specimens. A subset of genes manifesting significant differences in methylation frequencies between BE and EAC was then analysed in 20 dysplastic specimens. All 10 genes except p14 were frequently methylated in EACs, with RUNX3, HPP1, CRBP1, RIZ1, and OST-2 representing novel methylation targets in EAC and/or BE. p16, RUNX3, and HPP1 displayed increasing methylation frequencies in BE vs EAC. Furthermore, these increases in methylation occurred early, at the interface between BE and low-grade dysplasia (LGD). To demonstrate the silencing effect of hypermethylation, we selected the EAC cells BIC1, in which the HPP1 promoter is natively methylated, and subjected them to 5-aza-2′-deoxycytidine (Aza-C) treatment. Real-time RT–PCR indicated increased HPP1 mRNA levels after 3 days of Aza-C treatment, as well as decreased levels of methylated HPP1 DNA. Hypermethylation of a subset of six genes (APC, TIMP3, CRBP1, p16, RUNX3, and HPP1) was then tested in a retrospective longitudinal study of 99 BE and nine LGD specimens obtained from 53 BE patients undergoing surveillance endoscopy. Only high-grade dysplasia (HGD) or EAC were defined as progression end points. Two patient groups were compared: eight progressors (P) and 45 nonprogressors (NP), using Cox proportional hazards models to determine the relative progression risks of age, BE segment length, and methylation events. Multivariate analyses revealed that only hypermethylation of p16 (odds ratio (OR) 1.74, 95% confidence interval (CI) 1.33–2.20), RUNX3 (OR 1.80, 95% CI 1.08–2.81), and HPP1 (OR 1.77, 95% CI 1.06–2.81) were independently associated with an increased risk of progression, whereas age, BE segment length, and hypermethylation of TIMP3, APC, or CRBP1 were not independent risk factors. In combined analyses, risk was detectable up to, but not earlier than, 2 years preceding neoplastic progression. Hypermethylation of p16, RUNX3, and HPP1 in BE or LGD may represent independent risk factors for the progression of BE to HGD or EAC. These findings have implications regarding risk stratification, early EAC detection, and the appropriate endoscopic surveillance interval for patients with BE.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Alikhan M, Rex D, Khan A, Rahmani E, Cummings O and Ulbright TM . (1999). Gastrointest. Endosc., 50, 23–26.

  • Arber N, Lightdale C, Rotterdam H, Han KH, Sgambato A, Yap E, Ahsan H, Finegold J, Stevens PD, Green PH, Hibshoosh H, Neugut AI, Holt PR and Weinstein IB . (1996). Cancer Epidemiol. Biomarkers Prev., 5, 457–459.

  • Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A and Sontag SJ . (2002). Am. J. Gastroenterol., 97, 1930–1936.

  • Bae SC and Choi JK . (2004). Oncogene, 23, 4336–4340.

  • Bani-Hani K, Martin IG, Hardie LJ, Mapstone N, Briggs JA, Forman D and Wild CP . (2000). J. Natl. Cancer Inst., 92, 1316–1321.

  • Barrett MT, Sanchez CA, Galipeau PC, Neshat K, Emond M and Reid BJ . (1996). Oncogene, 13, 1867–1873.

  • Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, Rabinovitch PS and Reid BJ . (1999). Nat. Genet., 22, 106–109.

  • Bender CM, Gonzalgo ML, Gonzales FA, Nguyen CT, Robertson KD and Jones PA . (1999). Mol. Cell. Biol., 19, 6690–6698.

  • Bian YS, Osterheld MC, Fontolliet C, Bosman FT and Benhattar J . (2002). Gastroenterology, 122, 1113–1121.

  • Blot WJ and McLaughlin JK . (1999). Semin. Oncol., 26, 2–8.

  • Brown LM, Devesa SS and Fraumeni Jr JF . (2002). Atlas of Oncology: Cancer of the Upper Gastrointestinal Tract, Posner MC, Vokes EE and Weichselbaum RR (eds). BC Decker Inc.: London, pp. 1–22.

    Google Scholar 

  • Cameron AJ, Lomboy CT, Pera M and Carpenter HA . (1995). Gastroenterology, 109, 1541–1546.

  • Carling T, Du Y, Fang W, Correa P and Huang S . (2003). Surgery, 134, 932–939; discussion 939–940.

  • Chang HW, Chan A, Kwong DL, Wei WI, Sham JS and Yuen AP . (2003). Clin. Cancer Res., 9, 1033–1038.

  • Conio M, Blanchi S, Lapertosa G, Ferraris R, Sablich R, Marchi S, D'Onofrio V, Lacchin T, Iaquinto G, Missale G, Ravelli P, Cestari R, Benedetti G, Macri G, Fiocca R, Munizzi F and Filiberti R . (2003). Am. J. Gastroenterol., 98, 1931–1939.

  • Corley DA, Levin TR, Habel LA, Weiss NS and Buffler PA . (2002). Gastroenterology, 122, 633–640.

  • Corn PG, Heath E, Heitmiller R, Fogt F, Forastiere AA, Herman JG and Wu TT . (2001). Clin. Cancer Res., 7, 2765–2769.

  • Cox DR . (1972). J. Roy Statist. Soc. B, 34, 187–220.

  • Cox DR, Oakes D and Oakes DO . (1984). Analysis of Survival Data, 1st edn. CRC Press: Boca Raton, FL. ISBN: 041224490X.

    Google Scholar 

  • Drewitz DJ, Sampliner RE and Garewal HS . (1997). Am. J. Gastroenterol., 92, 212–215.

  • Du Y, Carling T, Fang W, Piao Z, Sheu JC and Huang S . (2001). Cancer Res., 61, 8094–8099.

  • Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV, Laird PW and Skinner KA . (2000). Cancer Res., 60, 5021–5026.

  • Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA and Laird PW . (2001). Cancer Res., 61, 3410–3418.

  • Esteller M . (2003). Lancet Oncol., 4, 351–358.

  • Esteller M, Guo M, Moreno V, Peinado MA, Capella G, Galm O, Baylin SB and Herman JG . (2002). Cancer Res., 62, 5902–5905.

  • Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS, Rabinovitch PS and Reid BJ . (1996). Proc. Natl. Acad. Sci. USA, 93, 7081–7084.

  • Galipeau PC, Prevo LJ, Sanchez CA, Longton GM and Reid BJ . (1999). J. Natl. Cancer Inst., 91, 2087–2095.

  • Geddert H, Kiel S, Iskender E, Florl AR, Krieg T, Vossen S, Gabbert HE and Sarbia M . (2004). Int. J. Cancer, 110, 208–211.

  • Gopal DV, Lieberman DA, Magaret N, Fennerty MB, Sampliner RE, Garewal HS, Falk GW and Faigel DO . (2003). Digest. Dis. Sci., 48, 1537–1541.

  • Hameeteman W, Tytgat GN, Houthoff HJ and van den Tweel JG . (1989). Gastroenterology, 96, 1249–1256.

  • Hamilton SR, Smith RR and Cameron JL . (1988). Hum. Pathol., 19, 942–948.

  • Hanley JA and McNeil BJ . (1982). Radiology, 143, 29–36.

  • Heath EI, Canto MI, Wu TT, Piantadosi S, Hawk E, Unalp A, Gordon G and Forastiere AA . (2003). Dis. Esophagus, 16, 177–186.

  • Herman JG and Baylin SB . (2003). N. Engl. J. Med., 349, 2042–2054.

  • Iftikhar SY, James PD, Steele RJ, Hardcastle JD and Atkinson M . (1992). Gut, 33, 1155–1158.

  • Issa JP . (1999). Crit. Rev. Oncol. Hematol., 32, 31–43.

  • Issa JP, Ahuja N, Toyota M, Bronner MP and Brentnall TA . (2001). Cancer Res., 61, 3573–3577.

  • Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE and Baylin SB . (1994). Nat. Genet., 7, 536–540.

  • Issa JP, Vertino PM, Boehm CD, Newsham IF and Baylin SB . (1996). Proc. Natl. Acad. Sci. USA, 93, 11757–11762.

  • Jankowski J and Sharma P . (2004). Aliment. Pharmacol. Ther., 19 (Suppl 1), 54–59.

  • Jones PA . (2003). Ann. N.Y. Acad. Sci., 983, 213–219.

  • Kang GH, Lee S, Lee HJ and Hwang KS . (2004). J. Pathol., 202, 233–240.

  • Kaplan EL and Meier P . (1958). J. Am. Stat. Assoc., 53, 457–481.

  • Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ and Kang GH . (2004). Lab. Invest., 84, 479–484.

  • Klump B, Hsieh CJ, Holzmann K, Gregor M and Porschen R . (1998). Gastroenterology, 115, 1381–1386.

  • Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC and Ito Y . (2002). Cell, 109, 113–124.

  • Li QL, Kim HR, Kim WJ, Choi JK, Lee YH, Kim HM, Li LS, Kim H, Chang J, Ito Y, Youl Lee K and Bae SC . (2004). Biochem. Biophys. Res. Commun., 314, 223–228.

  • Maley CC, Galipeau PC, Li X, Sanchez CA, Paulson TG and Reid BJ . (2004). Cancer Res., 64, 3414–3427.

  • McManus D, Olaru A and Meltzer S . (2004). Cancer Res., 64, 1561–1569.

  • Meltzer SJ, Mane SM, Wood PK, Resau JH, Newkirk C, Terzakis JA, Korelitz BI, Weinstein WM and Needleman SW . (1990). Cancer Res., 50, 3627–3630.

  • Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M and Tilanus HW . (1993). Cancer, 72, 1155–1158.

  • Miros M, Kerlin P and Walker N . (1991). Gut, 32, 1441–1446.

  • Miyamoto K, Asada K, Fukutomi T, Okochi E, Yagi Y, Hasegawa T, Asahara T, Sugimura T and Ushijima T . (2003). Oncogene, 22, 274–280.

  • Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toledano AY, Shyr Y and Washington K . (2001a). Hum. Pathol., 32, 368–378.

  • Montgomery E, Goldblum JR, Greenson JK, Haber MM, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Zahurak ML and Hart J . (2001b). Hum. Pathol., 32, 379–388.

  • Mori Y, Yin J, Sato F, Sterian A, Simms LA, Selaru FM, Schulmann K, Xu Y, Olaru A, Wang S, Deacu E, Abraham JM, Young J, Leggett BA and Meltzer SJ . (2004). Cancer Res., 64, 2434–2438.

  • Neshat K, Sanchez CA, Galipeau PC, Blount PL, Levine DS, Joslyn G and Reid BJ . (1994). Gastroenterology, 106, 1589–1595.

  • O'Connor JB, Falk GW and Richter JE . (1999). Am. J. Gastroenterol., 94, 2037–2042.

  • Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Chayama K and Yasui W . (2004a). Int. J. Cancer, 110, 212–218.

  • Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Ito Y, Chayama K and Yasui W . (2004b). Pathobiology, 71, 137–143.

  • Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC and DeMeester TR . (1994). J. Thorac. Cardiovasc. Surg., 108, 813–821.

  • Powell J and McConkey CC . (1992). Eur. J. Cancer Prev., 1, 265–269.

  • Rabinovitch PS, Longton G, Blount PL, Levine DS and Reid BJ . (2001). Am. J. Gastroenterol., 96, 3071–3083.

  • Reid BJ, Prevo LJ, Galipeau PC, Sanchez CA, Longton G, Levine DS, Blount PL and Rabinovitch PS . (2001). Am. J. Gastroenterol., 96, 2839–2848.

  • Sampliner RE . (2002). Am. J. Gastroenterol., 97, 1888–1895.

  • Sarbia M, Geddert H, Klump B, Kiel S, Iskender E and Gabbert HE . (2004). Int. J. Cancer, 111, 224–228.

  • Sato F, Harpaz N, Shibata D, Xu Y, Yin J, Mori Y, Zou TT, Wang S, Desai K, Leytin A, Selaru FM, Abraham JM and Meltzer SJ . (2002a). Cancer Res., 62, 1148–1151.

  • Sato F, Shibata D, Harpaz N, Xu Y, Yin J, Mori Y, Wang S, Olaru A, Deacu E, Selaru FM, Kimos MC, Hytiroglou P, Young J, Leggett B, Gazdar AF, Toyooka S, Abraham JM and Meltzer SJ . (2002b). Cancer Res., 62, 6820–6822.

  • Schnell TG, Sontag SJ and Chejfec G . (1992). Digest. Dis. Sci., 37, 137–143.

  • Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, Seidel UJ and Sonnenberg A . (2001). Gastroenterology, 120, 1607–1619.

  • Shaheen N and Ransohoff DF . (2002). JAMA, 287, 1972–1981.

  • Sharma P, Reker D, Falk GW, Johnston M, Weston AP and Sampliner RE . (2001). Gastroenterology, 120, A16.

  • Sharma P, Weston AP, Morales T, Topalovski M, Mayo MS and Sampliner RE . (2000). Gut, 46, 9–13.

  • Shibata DM, Sato F, Mori Y, Perry K, Yin J, Wang S, Xu Y, Olaru A, Selaru F, Spring K, Young J, Abraham JM and Meltzer SJ . (2002). Cancer Res., 62, 5637–5640.

  • Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE and Goldblum JR . (2000). Am. J. Gastroenterol., 95, 3383–3387.

  • Soldes OS, Kuick RD, Thompson II IA, Hughes SJ, Orringer MB, Iannettoni MD, Hanash SM and Beer DG . (1999). Br. J. Cancer, 79, 595–603.

  • Spechler SJ . (2002). N. Engl. J. Med., 346, 836–842.

  • Streitz Jr JM, Andrews Jr CW and Ellis Jr FH . (1993). J. Thorac. Cardiovasc. Surg., 105, 383–387.

  • Sullivan Pepe M, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M and Yasui Y . (2001). J. Natl. Cancer Inst., 93, 1054–1061.

  • Suzuki H, Zhou X, Yin J, Lei J, Jiang HY, Suzuki Y, Chan T, Hannon GJ, Mergner WJ and Abraham JM . (1995). Hum. Mol. Genet., 4, 1883–1887.

  • Teodori L, Gohde W, Persiani M, Ferrario F, Tirindelli Danesi D, Scarpignato C, Di Tondo U, Alo P and Capurso L . (1998). Cytometry, 34, 257–263.

  • Tokumaru Y, Nomoto S, Jeronimo C, Henrique R, Harden S, Trink B and Sidransky D . (2003). Oncogene, 22, 6954–6958.

  • Tseng EE, Wu TT, Yeo CJ and Heitmiller RF . (2003). J. Gastrointest. Surg., 7, 164–170; discussion 170–171.

  • van der Burgh A, Dees J, Hop WC and van Blankenstein M . (1996). Gut, 39, 5–8.

  • Waki T, Tamura G, Sato M, Terashima M, Nishizuka S and Motoyama T . (2003). Cancer Sci., 94, 360–364.

  • Weston AP, Badr AS and Hassanein RS . (1999). Am. J. Gastroenterol., 94, 3413–3419.

  • Weston AP, Banerjee SK, Sharma P, Tran TM, Richards R and Cherian R . (2001). Am. J. Gastroenterol., 96, 1355–1362.

  • Weston AP, Krmpotich PT, Cherian R, Dixon A and Topalosvki M . (1997). Am. J. Gastroenterol., 92, 407–413.

  • Williamson WA, Ellis Jr FH, Gibb SP, Shahian DM, Aretz HT, Heatley GJ and Watkins Jr E . (1991). Arch. Intern. Med., 151, 2212–2216.

  • Wong DJ, Barrett MT, Stoger R, Emond MJ and Reid BJ . (1997). Cancer Res., 57, 2619–2622.

  • Wong DJ, Paulson TG, Prevo LJ, Galipeau PC, Longton G, Blount PL and Reid BJ . (2001). Cancer Res., 61, 8284–8289.

  • Xiao WH and Liu WW . (2004). World J. Gastroenterol., 10, 376–380.

Download references

Acknowledgements

This work was supported in part by a grant of the Mildred Scheel Foundation of German Cancer Aid (Deutsche Krebshilfe) (KS) and NIH grants CA85069, CA01808, CA95323, CA098450, CA77057 and The Medical Research Service of the Department of Veterans Affairs (SJM).

Author information

Author notes

  1. Karsten Schulmann and Anca Sterian: These two authors contributed equally to this work

Authors and Affiliations

  1. Division of Gastroenterology, School of Medicine, University of Maryland, Baltimore, MD, USA

    Karsten Schulmann, Anca Sterian, Agnes Berki, Jing Yin, Yan Xu, Andreea Olaru, Suna Wang, Yuriko Mori, Elena Deacu, James Hamilton, Takatsugu Kan, John M Abraham, Bruce D Greenwald & Stephen J Meltzer

  2. Ruhr-University Bochum, Medical Department, Knappschaftskrankenhaus, Bochum, Germany

    Karsten Schulmann & Wolff Schmiegel

  3. Department of Pathology, School of Medicine, University of Maryland, Baltimore, MD, USA

    Fumiaki Sato

  4. Greenebaum Cancer Center, Baltimore, MD, USA

    Fumiaki Sato, Yuriko Mori, Mark J Krasna, Bruce D Greenwald & Stephen J Meltzer

  5. Department of Surgery, School of Medicine, University of Maryland, Baltimore, MD, USA

    Mark J Krasna

  6. University of Michigan, Thoracic Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA

    David G Beer

  7. Data Management and Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    Margaret S Pepe & Ziding Feng

  8. Baltimore VA Hospital, Baltimore, MD, USA

    Stephen J Meltzer

Authors
  1. Karsten Schulmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anca Sterian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Agnes Berki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jing Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fumiaki Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yan Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andreea Olaru
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Suna Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yuriko Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Elena Deacu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. James Hamilton
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Takatsugu Kan
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Mark J Krasna
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. David G Beer
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Margaret S Pepe
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. John M Abraham
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Ziding Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Wolff Schmiegel
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Bruce D Greenwald
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Stephen J Meltzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen J Meltzer.

Additional information

Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulmann, K., Sterian, A., Berki, A. et al. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene 24, 4138–4148 (2005). https://doi.org/10.1038/sj.onc.1208598

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208598

Keywords

This article is cited by

Search

Advanced search

Quick links